Takeshi Takayasu
Overview
Explore the profile of Takeshi Takayasu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takami H, Matsutani M, Suzuki T, Takabatake K, Fujimaki T, Okamoto M, et al.
Neuro Oncol
. 2024 Nov;
27(3):828-840.
PMID: 39492661
Background: A previous Phase II clinical trial, conducted from 1995 to 2003, evaluated CNS germ cell tumors (GCTs) using a three-group treatment stratification based on histopathology. The primary objective of...
2.
Yasuoka Y, Yonezawa U, Nabika S, Takayasu T, Taguchi A, Ohbayashi N, et al.
Neurol Med Chir (Tokyo)
. 2024 Jun;
64(7):278-282.
PMID: 38839297
Dural dryness makes suturing difficult during dural closure after craniotomy. In this case, dural plasty is often performed using a membrane taken from the surrounding tissue (e.g., fascia or periosteum)...
3.
Dono A, Zhu P, Takayasu T, Arevalo O, Riascos R, Tandon N, et al.
Neurosurgery
. 2024 Apr;
95(4):932-940.
PMID: 38687046
Background And Objectives: Maximizing the extent of resection (EOR) improves outcomes in glioblastoma (GBM). However, previous GBM studies have not addressed the EOR impact in molecular subgroups beyond IDH1/IDH2 status....
4.
Onishi S, Yamasaki F, Amatya V, Takayasu T, Yonezawa U, Taguchi A, et al.
J Neurooncol
. 2023 Oct;
165(1):171-179.
PMID: 37831389
Background: The treatment response of primary central nervous system lymphomas (PCNSLs) is mainly evaluated using postcontrast T1-weighted imaging (T1WI). Because poorly enhanced lesions may contain residual tumors, the combination of...
5.
Onishi S, Yamasaki F, Kinoshita Y, Amatya V, Takayasu T, Yonezawa U, et al.
Jpn J Clin Oncol
. 2023 Jul;
53(10):905-911.
PMID: 37461193
Background: Radiation-induced sarcoma (RIS) is among the neoplasms potentially caused by radiation therapy (RT) for brain tumors. However, the clinical characteristics of and ideal treatment for RIS are unclear. We...
6.
Onishi S, Yamasaki F, Kuraoka K, Taguchi A, Takayasu T, Akagi K, et al.
BMC Med Genomics
. 2023 Jan;
16(1):6.
PMID: 36647049
Background: Constitutional mismatch repair deficiency (CMMRD) results from a biallelic germline pathogenic variant in a mismatch repair (MMR) gene. The most common CMMRD-associated malignancies are brain tumors; an accurate diagnosis...
7.
Maeda Y, Onishi S, Yamasaki F, Takayasu T, Yonezawa U, Taguchi A, et al.
Jpn J Clin Oncol
. 2022 Dec;
53(3):212-220.
PMID: 36524362
Background: Secondary meningioma after cranial irradiation, so-called radiation-induced meningioma, is one of the important late effects after cranial radiation therapy. In this report, we analyzed our case series of secondary...
8.
Khairunnisa N, Yamasaki F, Amatya V, Takayasu T, Yonezawa U, Taguchi A, et al.
NMC Case Rep J
. 2022 Dec;
9:395-400.
PMID: 36518906
Temozolomide is an oral alkylating agent with moderate side effects compared to other agents. However, the development of secondary malignancies following temozolomide has been reported. We describe the first case...
9.
Kinoshita Y, Yamasaki F, Taguchi A, Takayasu T, Yonezawa U, Tominaga A, et al.
Pituitary
. 2022 Aug;
25(6):854-860.
PMID: 35986827
Purpose: Due to the effectiveness of growth hormone therapy (GHT), the number of cancer survivors receiving GHT has increased. Previous studies had indicated that GHT was not associated with the...
10.
Onishi S, Yamasaki F, Amatya V, Takayasu T, Yonezawa U, Taguchi A, et al.
J Neurooncol
. 2022 Aug;
159(3):531-538.
PMID: 35922583
Introduction: The so-called radiation-induced glioma (RIG, a secondary glioma after cranial irradiation), is a serious late effect after cranial radiation therapy. The clinical characteristics of and ideal treatment for these...